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ABSTRACT Since their emergence in 1997, A/H5N1 inﬂuenza viruses of the A/goose/
Guangdong/1/96 lineage have diversiﬁed in multiple genetic and antigenic clades
upon continued circulation in poultry in several countries in Eurasia and Africa. Since
2009, reassortant viruses carrying clade 2.3.4.4 hemagglutinin (HA) and internal and
neuraminidase (NA) genes of inﬂuenza A viruses of different avian origin have been
detected, yielding various HA-NA combinations, such as A/H5N1, A/H5N2, A/H5N3,
A/H5N5, A/H5N6, and A/H5N8. Previous studies reported on the low pathogenicity
and lack of airborne transmission of A/H5N2 and A/H5N8 viruses in the ferret model.
However, although A/H5N6 viruses are the only clade 2.3.4.4 viruses that crossed the
species barrier and infected humans, the risk they pose for human health remains
poorly characterized. Here, the characterization of A/H5N6 A/Guangzhou/39715/2014
virus in vitro and in ferrets is described. This A/H5N6 virus possessed high polymer-
ase activity, mediated by the E627K substitution in the PB2 protein, which corre-
sponds to only one biological trait out of the three that were previously shown to
confer airborne transmissibility to A/H5N1 viruses between ferrets. This might ex-
plain its lack of airborne transmission between ferrets. After intranasal inoculation,
A/H5N6 virus replicated to high titers in the respiratory tracts of ferrets and was ex-
creted for at least 6 days. Moreover, A/H5N6 virus caused severe pneumonia in fer-
rets upon intratracheal inoculation. Thus, A/H5N6 virus causes a more severe disease
in ferrets than previously investigated clade 2.3.4.4 viruses, but our results demon-
strate that the risk from airborne spread is currently low.
IMPORTANCE Avian inﬂuenza A viruses are a threat to human health, as they cross
the species barrier and infect humans occasionally, often with severe outcome. The
antigenic and genetic diversity of A/H5 viruses from the A/goose/Guangdong/1/96
lineage is increasing, due to continued circulation and reassortment in poultry, pos-
ing a constant risk for public health and requiring regular risk assessments. Here we
performed an in-depth characterization of the properties of the newly emerged zoo-
notic A/H5N6 virus in vitro and in ferrets. The lack of airborne transmission in the
ferret model indicates that A/H5N6 virus does not pose a direct public health threat,
despite the fact that it can replicate to high titers throughout the respiratory tracts
of ferrets and cause more severe disease than other clade 2.3.4.4 viruses.
KEYWORDS 2.3.4.4, ferrets, highly pathogenic avian inﬂuenza, pathogenesis,
transmission
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Highly pathogenic avian inﬂuenza (HPAI) A/H5 viruses of the A/goose/Guangdong/1/1996 (GsGd) lineage ﬁrst emerged in Hong Kong in 1997 (1). Since 2003, these
viruses have spread to Eurasia and Africa, and the GsGd lineage is the only lineage of
HPAI viruses that are endemic in poultry. As a result of continuous circulation in poultry,
the hemagglutinin (HA), the main antigenic determinant of inﬂuenza A viruses, of A/H5
GsGd viruses diversiﬁed in several genetic and antigenic clades (2). Moreover, due to
the segmented nature of the inﬂuenza A virus genome, viruses carrying GsGd HAs
reassorted with cocirculating low-pathogenic avian inﬂuenza (LPAI) viruses from do-
mestic and wild birds, increasing the genetic diversity of A/H5 GsGd viruses. In
particular, the H5 HA of clade 2.3.4.4 was found to reassort frequently with neuramin-
idase (NA) genes of other subtypes than N1, yielding A/H5 viruses with various HA-NA
combinations: A/H5N1, A/H5N2, A/H5N3, A/H5N5, A/H5N6, and A/H5N8 (3).
In contrast to A/H5N8 viruses, which spread worldwide in a global fashion via wild
migratory birds (4), the distribution of A/H5N6 viruses has until recently been limited to
China, Laos, and Vietnam. In China, they have replaced A/H5N1 viruses and became the
dominant A/H5 GsGd circulating virus in poultry (5). However, A/H5N6 viruses genet-
ically related to the viruses from China were isolated during the 2016-2017 winter from
wild migratory birds in Korea and Japan, where they also caused poultry outbreaks
(6–8), suggesting a potential for A/H5N6 viruses to spread via wild bird migration also.
A/H5N6 viruses are the only clade 2.3.4.4 viruses that have crossed the species
barrier and infected humans. The ﬁrst human cases of infection with the two circulating
lineages of A/H5N6 viruses were both reported in China (9, 10). As of 8 December 2017,
a total of 17 patients infected with A/H5N6 have been reported, and 6 of these patients
died (11). Almost all patients infected with A/H5N6 viruses had documented exposure
to infected poultry at live poultry markets, suggesting poultry exposure as a potential
source of zoonotic transmission (12). The ﬁrst reassortant A/H5N6 viruses identiﬁed in
April 2013 and the viruses isolated from the ﬁrst three human cases in 2014 were
carrying the internal genes of A/H5N1 viruses. Based on the origin of their HA and NA
genes, these viruses belong to two genotypes (G1 and G2). After 2014, multiple other
genotypes emerged upon reassortment with circulating A/H9N2 or A/H7N9 viruses (5,
12, 13), resulting in the deﬁnition of 34 genotypes (5).
The global spread via wild birds and complex reassortment history of clade 2.3.4.4
viruses required a detailed molecular and phenotypic characterization, especially of
the newly emerged A/H5N6 viruses. Several research groups previously reported on the
low pathogenicity and lack of airborne transmissibility in the ferret model of the
Korean, European, and North American A/H5N8 viruses and North American A/H5N2
viruses, probably partially due to the presence of internal genes originating from wild
bird LPAI viruses (14–16). In contrast, A/H5N6 viruses carry internal genes coming from
A/H5N1, A/H7N9, and A/H9N2 viruses, which are poultry-adapted viruses that have
themselves caused zoonotic infections or acted as donors of internal genes to most
other zoonotic inﬂuenza viruses (5).
Here, we focused our investigation on A/H5N6 A/Guangzhou/39715/2014 (GZ/14)
virus, which belongs to genotype G1 and caused one of the ﬁrst human cases of
A/H5N6 infection in 2014 (17). In vitro characterization of phenotypes that have been
associated with airborne (respiratory droplets and aerosols) transmission of A/H5N1
viruses, such as receptor binding preference, thermostability, pH stability, and poly-
merase activity was performed. The potential of A/H5N6 GZ/14 to transmit via the
airborne route between ferrets was assessed, as well as its pathogenicity in the ferret
model. While our study suggests that the public health risk posed by this A/H5N6 virus
is low, the A/H5N6 GZ/14 showed a high polymerase activity mediated by the E627K
substitution in PB2, replicated to higher titers in the respiratory tracts of ferrets and was
more pathogenic than a clade 2.3.4.4 A/H5N8 virus (14).
RESULTS
A/H5N6 GZ/14 virus binds to avian-type receptors. The inﬂuenza A virus HA
protein binds to host cells via sialylated receptors. Avian and human viruses bind
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2,3-linked sialic acids (2,3-SA, avian-type receptors) and 2,6-linked sialic acids
(2,6-SA, human-type receptors), respectively. In order to assess the receptor speciﬁcity
of A/H5N6 GZ/14, a resialylated red blood cell assay was performed. Brieﬂy, SA were
stripped off turkey red blood cells (TRBCs) upon sialidase treatment (Vibrio cholerae
neuraminidase [VCNA]), and either 2,3-SA or 2,6-SA were subsequently rebuilt using
speciﬁc sialyltransferases. Both control viruses, the avian A/H5N1 virus A/Indonesia/5/
2005 (IN/05) and the human A/H3N2 virus A/Netherlands/213/2003 (NL/03), displayed
the expected receptor attachment pattern by binding exclusively to 2,3-SA and
2,6-SA, respectively (Table 1). Viruses of clade 2.3.4.4, A/H5N6 GZ/14 and A/H5N8
A/chicken/Netherlands/EMC-3/2014 (ck/NL/14), displayed a phenotype of typical avian
viruses by binding exclusively to 2,3-SA.
A/H5N6 GZ/14 HA is unstable. Upon virus attachment to SA receptors on the cell
surface and internalization into endosomes, a low-pH-triggered conformational change
of HA mediates fusion of the viral and endosomal membranes to release the viral
genome in the cytoplasm (18). In order to assess the acid stability of the HA of A/H5N6
GZ/14, a syncytium formation assay was performed to measure the pH threshold
required for HA-mediated cell-to-cell fusion. Vero cells were transfected with plasmids
expressing different HAs and exposed to trypsin to cleave and activate the HA, followed
by acidiﬁcation of the cell culture by a pH gradient ranging from pH 4.8 to 5.9. Visual
inspection of the cell cultures for the presence of syncytia (multinucleated cells) was
used to determine the pH threshold triggering the conformational change and subse-
quent membrane fusion (Fig. 1A). Control HAs, the A/H5N1 IN/05 wild-type (WT) HA
(unstable), the A/H5N1 IN/05 HA carrying airborne-transmission substitutions (H103Y,
T156A, Q222L, and G224S [H5 numbering used throughout]) (stable), and the human
A/H3N2 NL/03 HA (stable), were included. The pH values at which cell-to-cell fusion was
triggered by A/H5N6 GZ/14 HA and A/H5N8 ck/NL/14 HA were 5.6 and 5.8, respectively,
which were similar to or higher than those of the unstable A/H5N1 IN/05 WT HA (pH
5.6) and higher than the two stable HAs, A/H5N1 IN/05 airborne (pH 5.3) and A/H3N2
NL/03 (pH 5.3).
The conformational change of HA from a metastable nonfusogenic state to a stable
fusogenic state can also be triggered at neutral pH when the HA is exposed to
increasing temperatures (19). Therefore, the thermostability was assessed using a
temperature sensitivity assay to further assess HA stability (Fig. 1B). Viruses were
exposed to a temperature gradient ranging from 50 to 60°C for 30 min, and the HA titer
was subsequently recorded. In agreement with the results of the fusion assay, A/H5N6
GZ/14 and A/H5N8 ck/NL/14 viruses were less stable than the human A/H3N2 and the
airborne transmissible A/H5N1 virus.
A/H5N6 GZ/14 possesses a high polymerase activity, mediated by the E627K
substitution in PB2. To measure the polymerase activity of A/H5N6 GZ/14, minirep-
licon assays were performed by transfecting 293T cells with plasmids expressing the
polymerase genes (PB2, PB1, and PA) and the nucleoprotein (NP) of different GsGd
TABLE 1 Receptor speciﬁcity of the different viruses as determined by a modiﬁed TRBC
hemagglutination assaya
Virus
HA titer with the following erythrocytes (TRBCs) (HAUb/25 l)
Untreated VCNA 2,3c 2,6c
A/H5N1 IN/05
(2,3-SA control)
64 1 64 1
A/H3N2 NL/03
(2,6-SA control)
32 1 1 32
A/H5N6 GZ/14 64 1 64 1
A/H5N8 ck/NL/14 64 1 64 1
aTwo independent experiments were performed, and results presented here are from one representative
experiment. VCNA, Vibrio cholerae neuraminidase.
bHAU, hemagglutination units.
cSA stripped off TRBCs upon sialidase treatment, and either 2,3-SA or 2,6-SA was subsequently rebuilt
using speciﬁc sialyltransferases.
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viruses, human A/H1N1 virus or avian A/H5N2 virus, luciferase (Renilla) as an internal
control, and luciferase (ﬁreﬂy) as a reported gene. The experiment was performed at
33°C and 37°C. Polymerase activities were expressed as a percentage of the polymerase
activity of the human A/H1N1 virus, HK/98, which was set at 100% for both tempera-
tures. At 33°C, the polymerase activity of the A/H5N6 GZ/14 was higher than that of
other viruses tested, including A/H5N1 IN/05 and A/H5N8 ck/NL/14 (Fig. 2). At 37°C, the
polymerase activity of A/H5N6 GZ/14 was similar to that of A/H5N1 IN/05 and higher
than that of the other viruses tested. A/H5N6 GZ/14 possesses a lysine at position 627
in the polymerase basic 2 (PB2), which has been associated with adaptation of avian
FIG 1 pH threshold of fusion stability and thermostability of clade 2.3.4.4 A/H5 viruses. (A) Syncytium
formation in Vero-118 cells upon expression of HAs from different A/H5 viruses and acidiﬁcation at different
pH values. Pictures corresponding to the last pH at which maximum syncytium formation was observed
(deﬁned as the pH threshold of fusion) and 0.1 pH unit higher are shown. Some areas showing fusion
(syncytia) are indicated by black arrows. Three independent experiments were performed, and results
presented here are from one representative experiment. (B) HA protein thermostability was measured by
the ability of viruses to agglutinate TRBCs after incubation for 30 min at the indicated temperatures
(Celsius). Colors indicate the HA titers upon treatment at various temperatures as shown in the color key
(HA titer/25 l). Three independent experiments were performed, and results presented here are from one
representative experiment.
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viruses to mammalian hosts (20–22). In order to understand whether the high poly-
merase activity of A/H5N6 GZ/14 was the result of the presence of PB2-627K, the PB2
gene of A/H5N6 GZ/14 was mutated to the avian genotype (K627E). The polymerase
activities of the A/H5N6 GZ/14 PB2-627E were 7 and 32 times lower than those of
A/H5N6 GZ/14 at 33°C and 37°C, respectively. It was also lower than that of A/H5N1
viruses isolated from human cases of infection (A/H5N1 IN/05 and A/H5N1 VN/1203/04)
and comparable to that of other avian viruses, A/H5N2 Ml/NL/99 and A/H5N8 ck/NL/14.
These observations demonstrated that the high polymerase activity of A/H5N6 GZ/14
was mediated by the E627K substitution in PB2.
A/H5N6 GZ/14 does not transmit between ferrets via the airborne route.
Human inﬂuenza viruses are known to be transmitted from person to person via the
airborne route by aerosols or respiratory droplets. Therefore, it is of importance to
investigate the airborne transmissibility of emerging inﬂuenza A viruses. Here, airborne
transmission experiments were performed in ferrets. Brieﬂy, one day after donor ferrets
were inoculated with A/H5N6 GZ/14, naive recipient ferrets were placed in an adjacent
cage, separated from the donor cage by a steel grid, allowing viruses to be transmitted
only via the airborne route. Virus shedding from the inoculated ferrets was high, with
titers up to 105.25 50% tissue culture infective doses (TCID50)/ml, and long-term, until
7 days postinoculation (dpi) (Fig. 3). Upon exposure, no replicating virus was detected
in any of the recipient ferrets. Lack of transmission was conﬁrmed by the absence of
seroconversion 14 days postexposure in all recipient ferrets (data not shown).
A/H5N6 GZ/14 is more pathogenic than a clade 2.3.4.4 A/H5N8 virus. In order
to assess the pathogenicity of A/H5N6 GZ/14, six ferrets were inoculated intranasally
with 106 TCID50 of virus. Daily, the animals were monitored for body weight and clinical
signs. Nose and throat swabs were also collected daily. At 3 and 6 dpi, three animals
were sacriﬁced, and necropsies were performed. Data from this experiment were
compared to historical data on intranasal challenge of ferrets with A/H5N8 ck/NL/14
and A/H5N1 IN/05 (14).
A/H5N6 GZ/14-inoculated animals lost on average 13% of their starting body weight
(ranging from 9 to 18% at 6 dpi) (Fig. 4A). This body weight loss was intermediate
between that of A/H5N8-inoculated animals (3%) and that of A/H5N1-inoculated
animals (21%). At 3 dpi, all animals were less active and exhibited rufﬂed fur and watery
eyes. One ferret was particularly weak, especially in the hind legs and did not move
when stimulated. At 4 dpi, all ferrets presented with rufﬂed fur and with weak hind legs,
showed inappetence, and kept their eyes slightly closed. At 6 dpi, all animals regained
FIG 2 Polymerase activity of clade 2.3.4.4 A/H5 viruses. 293T cells were transfected with plasmids
containing PB2, PB1, PA, and NP genes, a luciferase (ﬁreﬂy) reporter plasmid, and a control luciferase
(Renilla) reporter plasmid. After transfection, the 293T cells were cultured at 33°C (light gray) and 37°C
(dark gray) for 24 h, and luciferase activity was evaluated from the cell extracts. Results are presented as
the means standard deviations (error bars) of polymerase activity of virus compared to the polymerase
activity of the human A/H1N1 virus, HK/98, which was set at 100%, and are averages from three
independent experiments.
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activities, and their body weight stabilized. To summarize, A/H5N6 GZ/14-inoculated
animals showed more severe clinical signs than A/H5N8-inoculated animals, such as
inactivity or rufﬂed fur, as reﬂected by the global clinical score (Fig. 4A). However, they
did not progress to visible signs of pneumonia as observed in A/H5N1-inoculated
animals (14).
The shedding of A/H5N6 GZ/14 from the respiratory tracts of ferrets, as measured
by virus titration of throat and nose swab samples, was high and prolonged, similar to
that of A/H5N1 IN/05, and longer and higher in titers than those of A/H5N8 ck/NL/14
(Fig. 4B).
A/H5N6 GZ/14 virus was detected by virus titration at high titers in the nasal
turbinates, both at 3 dpi and 6 dpi (mean titers of 108.3 and 106.8 TCID50/g of tissue,
respectively) (Fig. 4C and D). Moreover, A/H5N6 GZ/14 virus was detected at 3 dpi in
more tissues of the respiratory tract, such as the lung and tonsils, and at higher titers
than of A/H5N8 ck/NL/14. At 3 dpi, A/H5N6 GZ/14 was indeed detected at a high titer
(107.1 TCID50/g of tissue) in the lung of one animal. A/H5N6 GZ/14 was also detected
at 3 dpi in extrarespiratory tissues such as the olfactory bulb (mean titers of 104.2
TCID50/g of tissue). At 6 dpi, A/H5N6 GZ/14 was detected only in the lung of one animal,
which was the animal that had lost the most weight (18%) (Fig. 4D). The low virus titers
in the brain, pancreas, and intestine at 3 dpi and 6 dpi were not conﬁrmed by
immunohistochemical analysis (IHC) detecting with the viral NP (Fig. 4C and D; Table 2).
At 3 dpi, high titers in the nasal turbinates correlated with the presence of virus
antigen in the caudal respiratory epithelium and more abundantly in the olfactory
FIG 3 Lack of airborne transmission of A/H5N6 GZ/14 between ferrets. Data for individual transmission experiments are shown in each
panel, with virus shedding from donor and recipient ferrets shown as lines and bars, respectively. Gray circles and squares represent
shedding from the throat; white circles and squares represent shedding from the nose. All virus titers were determined by endpoint
titration in MDCK cells. The lower limit of detection is indicated by the dashed lines.
Herfst et al.
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epithelium in the nose of all ferrets (Fig. 5; Table 2). Virus antigen expression was
associated with moderate epithelial necrosis and inﬁltration of some neutrophils and
macrophages in the caudal respiratory epithelium and with moderate to severe necro-
sis and inﬂammation in the olfactory epithelium. Gross pathology revealed multifocal
moderate gray-red consolidation and multifocal mild emphysema in the lung of one
ferret, in which virus titers were also detected (see above), with 50% of the lungs
affected and a relative lung weight (RLW) of 0.9%, expressed as a percentage of the
total body weight (Table 3). The RLW is a measure of the level of pulmonary inﬂam-
matory inﬁltrate and edema. In comparison, the median RLW of noninfected ferrets is
0.6% of total body weight, with a range from 0.5% to 0.8% (23). In the lungs of this
ferret, virus antigen expression was observed in few pneumocytes, more of the type II
than of the type I, and in a few alveolar macrophages (Table 2). Virus antigen expression
was associated with a mild to moderate inﬁltration of neutrophils, alveolar macro-
phages, edema, and epithelial necrosis. Moreover, there was a multifocal peribronchio-
lar cufﬁng with lymphocytes, macrophages, and plasma cells. The other two ferrets
presented with only 0% and 5% of the lung tissue affected (RLWs of 0.4% and 0.6%,
respectively), and no virus antigen expression nor microscopic lesions were observed
FIG 4 Body weight, activity status, and virus titers in swabs and tissues of ferrets upon intranasal inoculation with A/H5N6 GZ/14. (A)
Average body weight is represented by the dashed line and the open white circles (left y axis). Average activity status is represented
by the solid line and the closed black circles (right y axis). Activity status was scored daily as follows: 0, alert and playful; 1, alert and
playful only when stimulated; 2, alert but not playful when stimulated; 3, neither alert nor playful when stimulated. (B) Average virus
titers in the throat and nasal swabs are shown by the gray circles and white circles, respectively. (C) Virus titers in tissues collected
at 3 dpi are shown for individual ferrets in black, light gray, and dark gray. (D) Virus titers in tissues collected at 6 dpi are shown for
individual ferrets in black, light gray, and dark gray. All virus titers were determined by endpoint titration in MDCK cells. In panel B,
the lower limit of detection is indicated by the dotted line. In panels C and D, the lower limit of detection is indicated by the short
horizontal lines spanning the three bars for each tissue. All error bars represent standard deviations. Nasal turb., nasal turbinates;
Tracheobr. ln, tracheobronchial lymph node; Olf. bulb, olfactory bulb.
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by histopathology (Tables 2 and 3). In the olfactory bulbs of two ferrets, virus antigen
expression was observed in some cells that were associated with mild gliosis. In other
tissues, antigen expression was not demonstrated, and there were no signiﬁcant lesions
(Table 2).
At 6 dpi, virus antigen distribution in the nasal epithelium (respiratory and olfactory)
was similar to that of animals euthanized at 3 dpi albeit with fewer positive cells
(Table 2). Virus antigen expression was also associated with inﬂammation but with less
necrosis compared to 3 dpi. Moreover, one ferret presented lesions in 10% of his lungs
characterized by mild consolidation (RLW of 0.7%), while the other two ferrets showed
no lesions (RLWs of 0.7% and 0.8%). Microscopically, no virus antigen or lesions were
observed in the lungs of animals euthanized at 6 dpi. In the olfactory bulbs of two
TABLE 2 Virus antigen expression in tissues of ferrets inoculated intranasally or intratracheally with A/H5N6 GZ/14
System and tissue
Virus antigen expression in ferretsa
Intranasal challenge Intratracheal challenge
Necropsied at
3 dpi
Necropsied at
6 dpi
F1 F2 F3F1 F2 F3 F4 F5 F6
Respiratory
Nasal respiratory epithelium (rostral)         
Nasal respiratory epithelium (caudal)    /  /   
Nasal olfactory epithelium         
Nasal glands   /  / /   
Nasal stratiﬁed epithelium         
Larynx  /b    /   
Trachea     /    
Tracheal glands         
Bronchi         
Bronchial glands         
Bronchioles  /       
Alveoli, pneumocyte type 1  /     /  
Alveoli, pneumocyte type 2         
Alveolar macrophages         
Tonsil   X X X  X  
Tracheobronchial lymph node  / X    / / 
Extrarespiratory
Heart         
Liver      /c   
Spleen         
Kidney         
Adrenal         
Esophagus         
Duodenum         
Jejunum         
Colon         
Pancreas      /d   
Mesenteric lymph node  X       
Nervous
Nasal nerves         
Trigeminus nerve         
Olfactory bulb / /   / /   
Cerebrum         
Cerebellum         
Eye lid         
aViral antigen expression in individual ferrets (three ferrets per group). Ferrets are indicated as follows: F1, ferret 1; F2, ferret 2, etc. Symbols: , no virus antigen
(nucleoprotein) present; /, virus antigen expression in occasional cells; , virus antigen expression in a few cells; , virus antigen expression in a moderate
number of cells; , virus antigen expression in many cells; X, tissue sample not available.
bVirus antigen expression in occasional epithelial cells associated with mild mixed inﬂammatory inﬁltrate.
cFocal virus antigen expression in occasional cholangioductular epithelial cells associated with inﬁltration of a moderate number of macrophages and lymphocytes
and of a few neutrophils and plasma cells.
dVirus antigen expression in occasional pancreatic ductular epithelial cells. Multifocally, there was moderate interstitial edema and inﬁltration of macrophages,
neutrophils, lymphocytes, and plasma cells.
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ferrets, few cells in the glomerular zone were virus antigen positive associated with mild
gliosis.
A/H5N6 GZ/14 causes severe pneumonia upon intratracheal inoculation of
ferrets. Most humans infected with an HPAI A/H5 GsGd virus developed severe
pneumonia resulting in acute respiratory distress syndrome. Differences in virus tro-
pism and pathogenicity after different routes of inoculation of ferrets have already been
reported (24), and it has been shown that intranasal inoculation does not necessarily
result in the development of pneumonia, as seen in most human cases of infection.
Therefore, in order to study the ability of A/H5N6 GZ/14 to cause pneumonia, three
ferrets were inoculated intratracheally with 106 TCID50 of virus. At 1 dpi, all animals
were alert, but they were playful only after stimulation (activity status [AS] of 1). At 2
dpi, in the morning, one ferret was found dead, while the two other ferrets were less
FIG 5 Histopathological and immunohistochemical analyses of nasal epithelium samples from ferrets inoculated
intranasally with A/H5N6 GZ/14, collected at 3 dpi. (A) Schematic drawing of a cross section of a ferret head
illustrating the anatomical sites of the rostral respiratory epithelium (1), caudal respiratory epithelium (2), and
olfactory epithelium (3). (B) Hematoxylin and eosin (HE) staining of nasal turbinates of a naive ferret showing the
different epithelia. (C) HE staining of nasal turbinates of a ferret inoculated with A/H5N6 GZ/16 showing the
different epithelia. (D) Inﬂuenza A virus NP antigen expression as determined by IHC in the different epithelia of
the nasal turbinates of a ferret inoculated with A/H5N6 GZ/16. Arrows indicate cells positive for virus antigen NP
expression. The pictures in panels C and D were taken from the nasal turbinates of one animal inoculated with
A/H5N6 GZ/16 and serve as representative images for all animals. Magniﬁcation, 200.
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active than the day before (AS of 2). Later in the afternoon, these two ferrets were
neither alert nor playful when stimulated (AS of 3). One animal presented with severe
dyspnea and succumbed to the infection shortly after. The other ferret was very weak,
demonstrated swollen conjunctiva and mild dyspnea and was euthanized because of
its poor condition. The animal that died at 1 dpi had lost 6% of its starting body weight,
and the other two ferrets had lost 12% and 10% of their starting body weights.
At the time of death or euthanasia, between 1 dpi and 2 dpi depending on the
animal, virus titers were very high throughout the respiratory tract and with the highest
titers in the lungs (mean titers of 107.2 TCID50/g of tissue) (Fig. 6A).
Gross pathological analysis revealed a severe diffuse to coalescing pulmonary
consolidation affecting 90 to 100% of the lungs of all animals, characterized by dark red
and depressed lung parenchyma. The RLWs of these ferrets were between 1.3% and
1.6% (Table 3). The ferrets had enlarged tracheobronchial lymph nodes, approximately
two to three times the normal size. Microscopically, there was multifocal coalescing to
diffuse expression of virus antigen in many type II pneumocytes, in a moderate number
of type I pneumocytes, and few macrophages. Virus antigen expression was associated
with multifocal coalescing to severe diffuse alveolar damage (DAD) (Fig. 6D to G). DAD
was characterized by severe epithelial necrosis, large amounts of intraluminal protein-
aceous exudate (edema), ﬁbrin, extravasated erythrocytes (hemorrhage), cellular debris,
and inﬁltration of moderate numbers of viable and degenerated neutrophils and
increased numbers of alveolar macrophages. Around the bronchioles in the perivascu-
lar space, there was a mild to moderate inﬁltration of macrophages, lymphocytes, and
a few plasma cells and edema. In two ferrets, there was antigen present in a few
mononuclear cells of the tracheobronchial lymph node. In the other collected tissues,
virus antigen expression was not demonstrated, and signiﬁcant lesions were absent.
A/H5N6 GZ/14 is not recognized by ferret antisera raised against available
candidate vaccine viruses. To study the antigenic relationship between A/H5N6
GZ/14 and other clade 2.3.4.4 viruses and the neutralization of A/H5N6 GZ/14 by
postinfection antisera raised against available candidate vaccine viruses (CVVs), we
performed a hemagglutination inhibition (HI) assay (Table 4). Apart from the homolo-
gous antisera, A/H5N6 GZ/14 was recognized only by antisera raised against clade
2.3.4.4 A/H5N2 A/goose/Eastern China/1112/2011 (gs/EC/11). Therefore, none of the
CVVs elicited HI antibodies that cross-reacted with the A/H5N6 GZ/14 HA. Postinfection
antisera raised against A/H5N6 GZ/14 reacted only poorly to A/H5N8 ck/NL/14 and
A/H5N2-gs/EC/11, demonstrating antigenic divergence of A/H5 viruses within clade
2.3.4.4.
DISCUSSION
Here, we report on a detailed in vitro and in vivo characterization of the clade 2.3.4.4
A/H5N6 GZ/14 virus in order to evaluate the risk for humans. Sequence analysis of
A/H5N6 GZ/14 virus revealed a few amino acid substitutions that have previously
been described as mammalian adaptation markers for other A/H5 viruses of the GsGd
TABLE 3 Gross pathology of lungs of ferrets inoculated intranasally or intratracheally
with A/H5N6 GZ/14
Parameter
Value (%) for parameter in ferretsa
Intranasal challenge
Intratracheal
challenge
Necropsied at 3
dpi
Necropsied at 6
dpi
F1 F2 F3F1 F2 F3 F4 F5 F6
Affected lung tissue 0 50 5 0 0 10 100 90 100
Relative lung wtb 0.4 0.9 0.6 0.8 0.7 0.7 1.6 1.3 1.6
aFerrets are indicated as follows: F1, ferret 1; F2, ferret 2, etc.
bThe relative lung weight was expressed as a percentage of the total body weight at the time of the
necropsy. The median relative lung of noninoculated female ferrets is 0.6 (range, 0.5 to 0.8).
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lineage: 94N (25), 133A (25), and 235P (26) in HA, which have been associated with
increased binding of A/H5N1 viruses to human-type receptors, and E627K in PB2, which
has been associated with increased replication of inﬂuenza viruses in vitro and in vivo
at temperatures equivalent to those of the mammalian upper respiratory tract (URT)
(21, 22, 27). Despite the fact that our knowledge of the genetic markers of mammalian
adaptation is growing, performing risk assessment using genetic data alone might be
misleading because of context dependency. Therefore, we sought to perform a phe-
notypic characterization of A/H5N6 GZ/14 by focusing on the phenotypes that have
been associated with airborne transmission of A/H5N1 GsGd viruses (28, 29): a change
in receptor binding preference of HA from avian-type to human-type receptors, 2,3-SA
and 2,6-SA, respectively, increased HA thermostability and acid stability and increased
polymerase activity.
FIG 6 Virus titers in tissues of ferrets inoculated intratracheally with A/H5N6 GZ/14 and histopathological and immunohis-
tochemical analyses of the lungs at the time of death. (A) Individual virus titers in tissues at the time of death/euthanasia. All
titers were determined by endpoint titration in MDCK cells. The lower limit of detection is indicated by the short horizontal
lines spanning the three bars for each tissue type. Nasal turb., nasal turbinates; Tracheobr. ln, tracheobronchial lymph node;
Olf. bulb, olfactory bulb. (B) HE staining of a lung from a naive ferret. Magniﬁcation, 200. (C) HE staining of a lung from a
naive ferret. Magniﬁcation, 400. (D) HE staining of a lung from an A/H5N6 GZ/14-inoculated ferret. Magniﬁcation, 200. (E)
HE staining of a lung from an A/H5N6 GZ/14-inoculated ferret. Magniﬁcation, 400. (F) NP-positive staining of a lung from an
A/H5N6 GZ/14-inoculated ferret. Magniﬁcation, 200. (G) NP-positive staining of a lung from an A/H5N6 GZ/14-inoculated
ferret. Magniﬁcation, 400. The pictures shown in panels D and E and panels F and G show the lung from one animal and
serve as representative images for all animals.
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Using a resialylated TRBC assay, A/H5N6 GZ/14, as well as A/H5N8 ck/NL/14, was
shown to display a typical pattern of avian inﬂuenza viruses by binding exclusively to
2,3-SA. These data are in accordance with previous studies, in which A/H5N6 GZ/14
and another human A/H5N6 isolate, A/Sichuan/26221/2014, were found to bind only to
2,3-SA (30, 31). Interestingly, A/H5N6 viruses isolated from healthy ducks in China
bound in a similar fashion to both 2,3-SA and 2,6-SA as well as to both upper
(trachea) and lower (alveoli) respiratory epithelium (32). A/H5N6 viruses isolated from
wild bird carcasses in Hong Kong also displayed a dual binding phenotype (31). The
substitutions that mediated the binding of these avian A/H5N6 viruses to human-type
receptors were not identiﬁed. Although most clade 2.3.4.4 viruses have retained
2,3-SA speciﬁcity, it was shown that the emergence of clade 2.3.4.4 viruses was
accompanied with the capacity of these viruses to bind to fucosylated sialilosides,
mediated by K218Q and S223R, substitutions that are conserved in clade 2.3.4.4 HAs
(33). Of note, such modiﬁcations cannot be detected using the resialylated TRBC, in
which only the nature of the bondage between the terminal sialic acid and the
antepenultimate sugar is evaluated.
HA acid stability has been described as an important host range factor, associated
with adaptation of avian and swine inﬂuenza viruses to the human host, airborne
transmission of avian viruses, and pandemic potential (28, 29, 34–37). The HAs of
A/H5N6 GZ/14 and of A/H5N8 ck/NL/14 were unstable compared to those of a human
A/H3N2 virus and an avian-origin A/H5N1 transmissible virus assessed in syncytium
formation and thermostability assays. A/H5N6 GZ/14 and A/H5N8 ck/NL/14 do not
possess known substitutions that have been reported to increase the acid stability
and/or thermostability of A/H5 viruses from other clades of the GsGd lineage, such as
H103Y, T315I, or K58I (HA2 numbering) (28, 29, 38, 39).
Using a minireplicon assay, we demonstrated that A/H5N6 GZ/14 possessed a high
polymerase activity, which was mediated by E627K in PB2. Out of the 16 A/H5N6
human isolates, seven isolates carry the PB2-E627K, and one isolate, A/Sichuan/26221/
2014, carries the PB2-D701N substitution, which has also been associated with in-
creased replication and transmission in mammalian hosts (20, 40, 41). Acquisition of
PB2-E627K might be the result of adaptation to the human host, although this
substitution has also been detected in A/H5 avian virus isolates from other clades, as
well as in other avian-origin inﬂuenza viruses such as A/H7N9 (42).
Of the three virus traits that conferred airborne transmissibility to A/H5N1 viruses
between ferrets, A/H5N6 GZ/14 possesses only one of these traits, which is high
polymerase activity. On the basis of the results of these in vitro assays, we predicted
that A/H5N6 GZ/14 would not be transmissible via the airborne route, which was
conﬁrmed using the ferret model. Ferrets are used as animal models to study airborne
transmission of inﬂuenza viruses, as it was shown that human inﬂuenza viruses trans-
mit via the airborne route between ferrets, while avian inﬂuenza viruses do not,
TABLE 4 HI assay with ferret antisera raised against a panel of candidate A/H5 vaccine viruses for pandemic preparedness selected by
the WHO network
Virusa Subtype Clade
HI titerb against sera raised against the following virus:
ml/SW/02 HK/97 VN/04 IN/05 tk/TK/05 AN/05 ck/NL/14 gy/WAS/14 gs/EC/11 GZ/14
ml/SW/02 H5N9 Classic 160 480 160 30 120 80 20 10 10 10
HK/97 H5N1 0 10 480 320 10 10 10 10 10 10 10
VN/04* H5N1 1 10 10 960 10 10 10 10 10 10 10
IN/05* H5N1 2.1 10 30 40 640 10 40 10 10 10 10
tk/TK/05* H5N1 2.2 10 80 80 160 1,280 10 10 10 10 10
AN/05* H5N1 2.3.4 10 160 240 320 80 1,280 10 10 10 10
ck/NL/14 H5N8 2.3.4.4 10 10 40 10 10 10 960 640 320 10
gy/WAS/14* H5N8 2.3.4.4 10 10 10 10 10 10 240 160 60 10
gs/EC/11 H5N2 2.3.4.4 10 10 10 10 10 10 10 10 160 80
GZ/14 H5N6 2.3.4.4 10 10 10 10 10 10 10 10 160 320
aViruses marked with an asterisk are A/H5 candidate vaccine viruses.
bHomologous titers are boldface and underlined.
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corresponding to what is also observed in humans (28). Our results are in accordance
with a study on the transmissibility of clade 2.3.4.4 A/H5N6 viruses, isolated from
healthy ducks, that were transmitted only via the direct contact route but not via the
airborne route between ferrets (32). Other viruses of clade 2.3.4.4, A/H5N8 or A/H5N2,
were also found to not transmit via the airborne route between ferrets (14–16).
Previous studies have reported on the low pathogenicity of reassortant viruses of
clade 2.3.4.4, such as the Korean, European, and American A/H5N8 viruses and Amer-
ican A/H5N2 viruses in ferrets (14–16). However, in contrast to these viruses that had
acquired internal genes from LPAI viruses from wild birds, A/H5N6 GZ/14 possesses
internal genes from the A/H5N1 GsGd lineage and also the adaptive substitution E627K
in PB2 that might increase its pathogenicity in mammalian hosts. Ferrets are used as a
model organism to study the pathogenesis of inﬂuenza viruses, as their susceptibility
to infection with human and avian inﬂuenza viruses is similar to that of humans, and
they develop respiratory disease similar to that observed in humans. Using the ferret
model, we showed that the pathogenicity of A/H5N6 GZ/14 largely depends on the
route of inoculation, as described previously for A/H5N1 viruses (24). Upon intranasal
inoculation, the pathogenicity of A/H5N6 GZ/14 was intermediate between the patho-
genicities of A/H5N1 IN/05 and A/H5N8 ck/NL/14 (14). The virus was detected in the
olfactory bulb as early as 3 dpi, and it is possible that A/H5N6 GZ/14 would also be able
to spread to the brain as seen with A/H5N1 IN/05, 7 days after intranasal inoculation
(24, 43). Ferrets lost on average 13% of their body weight over the time of the
experiment, displayed more clinical signs than A/H5N8 ck/NL/14-inoculated ferrets, but
did not progress to pneumonia as seen in A/H5N1 IN/05-inoculated animals. Differ-
ences between A/H5N6 and A/H5N1 might just be due to the route of inoculation—
intranasal—which results in virus deposition in the lower respiratory tracts of some
ferrets but not necessarily all (23, 24). Therefore, to assess the ability of A/H5N6 GZ/14
to cause pneumonia, which is observed in most humans infected with A/H5 GsGd
viruses, ferrets were inoculated intratracheally with 106 TCID50 of virus. Upon intratra-
cheal challenge, all ferrets developed a severe and fatal pneumonia characterized by
severe DAD. High levels of replication of A/H5N6 GZ/14 in the lungs of infected ferrets
upon deposition of the virus in the lungs correlates with the study by Hui et al., in which
A/H5N6 GZ/14 was shown to replicate to very high titers in lung explants (31). Sun et
al. (32) also showed that A/H5N6 viruses isolated from healthy ducks were not as
pathogenic in ferrets as a 2.3.4 A/H5N1 virus, but these A/H5N6 viruses carried internal
genes from different origin.
To conclude, the results from this study demonstrate that an A/H5N6 virus of the G1
genotype is not fully adapted to mammalian hosts and therefore presents a low risk to
humans, although it caused more severe disease in ferrets than other clade 2.3.4.4
viruses. However, considering the diversity of genotypes among A/H5N6 viruses, more
extensive characterization and risk assessment of A/H5N6 viruses of different geno-
types is required in order to completely assess the risks. Moreover, owing to its
pathogenicity in ferrets and its antigenic divergence from other 2.3.4.4 A/H5 Gs/Gd
viruses, A/H5N6 GZ/14 virus could be used as a challenge candidate for vaccination/
challenge studies to assess the ability of different vaccination strategies to elicit
protective responses to emerging Gs/Gd HPAI viruses.
MATERIALS AND METHODS
Cells. Madin-Darby canine kidney (MDCK) cells (ATCC) were cultured in Eagle’s minimal essential
medium (EMEM) (Lonza) supplemented with 10% fetal bovine serum (FBS) (Greiner), 100 U/ml penicillin
(PEN) (Lonza), 100 U/ml streptomycin (STR) (Lonza), 2 mM L-glutamine (L-Glu) (Lonza), 1.5 mg/ml sodium
bicarbonate (NaHCO3) (Lonza), 10 mM HEPES (Lonza) and 1 nonessential amino acids (NEAA) (Lonza).
293T cells were cultured in Dulbecco modiﬁed Eagle’s medium (DMEM) (Lonza) supplemented with 10%
FBS, 100 U/ml PEN, 100 U/ml STR, 2 mM L-Glu, 1 mM NaHCO3, and 1 NEAA. Vero cells were cultured
in Iscove’s modiﬁed Dulbecco’s medium (IMDM) (Lonza) supplemented with 10% FBS, 100 U/ml PEN,
100 mg/ml STR, and 2 mM L-Glu.
Viruses. All eight gene segments of a human virus isolate, A/H5N6 A/Guangzhou/39715/2014
(GZ/14), were ampliﬁed from copy DNA by PCR using speciﬁc primers and cloned in a modiﬁed version
of the bidirectional reverse genetics plasmid pHW2000 (44). Recombinant viruses were rescued by
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reverse genetics upon transfection of 293T cells as previously described (44). For in vivo experiments, a
full recombinant A/H5N6 GZ/14 virus was used. For in vitro experiments (thermostability, resialylated
turkey red blood cell [TRBC], and hemagglutination inhibition assays), recombinant viruses containing six
gene segments of A/Puerto Rico/8/1934 (PR/34), the HA without the multibasic cleavage site (MBCS) and
the NA of A/H5N6 GZ/14 or A/H5N8 A/chicken/Netherlands/EMC-3/2014 (ck/NL/14) were used. Control
viruses for thermostability and resialylated red blood cell assays were recombinant viruses containing
seven gene segments of PR/34 and the corresponding HA without the MBCS (if applicable). Prototypic
viruses used in hemagglutination inhibition assay were recombinant viruses containing six gene seg-
ments of PR/34, the HA without the MBCS, and the NA of the corresponding virus with the exception of
the A/goose/Eastern China/1112/2011 and A/gyrfalcon/Washington/41088-6/2014, which was a recom-
binant virus carrying seven genes of PR/34 and the corresponding HA. Virus stocks were propagated up
to three times in MDCK cells and titrated in MDCK cells as described below. The sequences of the virus
stocks used for every experiment were checked using Sanger sequencing. Virus names were abbreviated
as follows: A/Indonesia/5/2005 (IN/05), A/Netherlands/213/2003 (NL/03), A/Mallard/Sweden/49/2002
(ml/SW/02), A/Hong Kong/156/1997 (HK/97), A/Vietnam/1194/2004 (VN/04), A/turkey/Turkey/1/2005
(tk/TK/05), A/Anhui/1/2005 (AN/05), A/gyrfalcon/Washington/41088-6/2014 (gy/WAS/14), and A/goose/
Eastern China/1112/2011 (gs/EC/11).
Titrations.MDCK cells were inoculated with 10-fold serial dilutions of virus stocks, nose swabs, throat
swabs, or homogenized tissue samples. The cells were washed with phosphate-buffered saline (PBS) 1 h
after inoculation and cultured in infection medium, consisting of EMEM supplemented with 100 U/ml
PEN, 100 U/ml STR, 2 mM L-Glu, 1.5 mg/ml NaHCO3, 10 mM HEPES, 1 NEAA, and 20 g/ml trypsin
(N-tosyl-L-phenylalanine chloromethyl ketone [TPCK]-treated trypsin; Sigma). Three days after inocula-
tion, supernatants of cell cultures were tested for agglutinating activity using TRBCs as an indicator of
virus replication. Infectious virus titers were calculated from 4 replicates each of the homogenized tissue
samples, nose swabs, and throat swabs and from 10 replicates of the virus stocks by the method of Reed
and Muench (45).
Ferret experiments. Ferrets were housed and experiments were conducted in strict compliance with
European guidelines (European Union [EU] directive on animal testing 86/609/EEC) and Dutch legislation
(Experiments on Animals Act, 1997). All animal experiments were approved by the independent animal
experimentation ethical review committee “stichting dier experimenten commissie (DEC) consult” (Eras-
mus MC permit number EMC4028). Research projects involving laboratory animals can be executed only
if they are approved by the animal experiments committee (DEC). The DEC considers the application and
pays careful attention to the effects of the intervention on the animal and its discomfort and weighs this
against the social and scientiﬁc beneﬁt to humans or animals. The researcher is required to keep the
effects of the intervention to a minimum, based on the three R’s (reﬁnement, replacement, reduction).
(i) Ferret transmission experiments. Four ferrets were inoculated intranasally with a total dose of
106 TCID50 of virus distributed into the two nostrils (250 l per nostril). Each donor ferret was then placed
in a transmission cage. One day after inoculation, one naive recipient ferret was placed opposite of each
donor ferret. Each transmission pair was housed in a separate transmission cage designed to prevent
direct contact but to allow airﬂow from the donor ferret to the recipient ferret. Nose and throat swabs
were collected at 1, 3, 5, and 7 days postinoculation (dpi) from donor ferrets and at 1, 3, 5, 7, and 9 days
postexposure (dpe) from the recipient ferrets and subjected to endpoint titration in MDCK cells. Donor
ferrets were euthanized at 7 dpi and recipient ferrets were euthanized at 14 dpe to allow assessment of
seroconversion.
(ii) Ferret pathogenesis experiments. Six ferrets were inoculated intranasally with a total dose of
106 TCID50 of A/H5N6 GZ/14 by applying 250 l of virus suspension dropwise to each nostril. Clinical
scores in all groups were assessed every day. Activity status was scored as follows: 0, alert and playful;
1, alert and playful only when stimulated; 2, alert but not playful when stimulated; 3, neither alert nor
playful when stimulated. Dyspnea was characterized by open-mouth breathing with exaggerated
abdominal movement (46). Body weight was recorded daily. Throat and nose swabs were collected every
day and were stored at 80°C in transport medium (Hanks’ balanced salt solution containing 0.5%
lactalbumin [Sigma], 10% glycerol [Sigma], 200 U/ml PEN, 200 mg/ml STR, 100 U/ml polymyxin B sulfate
[Sigma], and 250 mg/ml gentamicin [Gibco]) for endpoint titration in MDCK cells. At 3 and 6 dpi, three
animals from each group were euthanized by exsanguination under anesthesia and were necropsied
according to a standard protocol (46). Tissues harvested for virological examination (right nasal turbi-
nates, trachea, right bronchus, right lungs, tracheobronchial lymph nodes, right tonsils, right olfactory
bulb, right cerebrum, right cerebellum, heart, liver, spleen, kidney, adrenal gland, pancreas, and jejunum)
were homogenized in transport medium using the FastPrep system (MP Biomedicals) with two one-
quarter-inch ceramic sphere balls, centrifuged 1,500  g for 10 min, aliquoted, and stored at 80°C for
endpoint titration in MDCK cells. Tissues harvested for histological examination (nasal turbinates, larynx,
trachea, left bronchus, left lung, tracheobronchial lymph nodes, heart, liver, spleen, kidney, adrenal gland,
esophagus, duodenum, jejunum, colon, pancreas, mesenteric lymph node, left olfactory bulb, left
cerebrum, left cerebellum, and eye lid) were ﬁxed in 10% neutral buffered formalin, embedded in
parafﬁn, sectioned at 4 m, and stained with hematoxylin and eosin (HE) for examination by light
microscopy.
In a second experiment, three ferrets were inoculated intratracheally with 3 ml of virus dilution
containing 106 TCID50. The experimental design and procedures were similar to those performed for the
intranasal inoculation.
Immunohistochemistry (IHC). For detection of inﬂuenza A virus antigen, sequential slides of all
tissues were stained with a primary antibody against the inﬂuenza A virus nucleoprotein (NP) as
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described previously (46). In each staining procedure, an isotype control was included as a negative
control, and a lung section from a cat infected experimentally with A/H5N1 was used as a positive
control.
Resialylated turkey red blood cell assay. All sialic acids (SA) were removed from the surfaces of
TRBCs by incubating 1% TRBCs in PBS with 50 mU of Vibrio cholerae NA (VCNA) (Roche) in 8 mM calcium
chloride (CaCl2) at 37°C for 1 h. After two washing steps with PBS, VCNA-treated TRBCs were resuspended
in PBS containing 1% bovine serum albumin (BSA) to a ﬁnal concentration of 0.5% TRBCs. Removal of SA
was conﬁrmed by observation of a complete loss of hemagglutination of the TRBCs by control inﬂuenza
A viruses. Subsequently, resialylation was performed using 0.5 mU of 2,3-N-sialyltransferase (Sigma) or
25 mU of 2,6-N-sialyltransferase (Sigma) and 1.5 mM CMP-sialic acid (Merck) at 37°C for 2 h in a ﬁnal
volume of 75 l to produce 2,3-TRBCs and 2,6-TRBCs, respectively. After two washing steps, the TRBCs
were resuspended in PBS containing 1% BSA to a ﬁnal concentration of 0.5% TRBCs. Resialylation was
conﬁrmed by hemagglutination of viruses with known receptor speciﬁcity: A/H5N1 IN/05 and A/H3N2
NL/13. The receptor speciﬁcity of A/H5N8 ck/NL/14 and A/H5N6 GZ/14 was tested by performing a
standard hemagglutination assay with the modiﬁed TRBCs.
Syncytium formation assay. Inﬂuenza virus HA-induced cell fusion was tested in Vero-118 cells
transfected with 5 g of HA cloned in pCAGGs expression plasmid using Xtremegene transfection
reagent according to the manufacturer’s instructions (Roche). One day after transfection, the cells were
harvested using trypsin-EDTA and plated in 24-well plates. The next morning, the cells were washed, and
medium was replaced with IMDM (Lonza) containing 10 g/ml of trypsin. After 1 h, the cells were washed
with PBS and exposed to PBS at pH 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, or 5.9 for 10 min at 37°C.
Subsequently, the PBS was replaced by IMDM supplemented with 10% FBS, 100 U/ml PEN, 100 mg/ml
STR, and 2 mM L-Glu. The next day, the cells were ﬁxed using 80% ice-cold acetone, washed, and stained
using a 20% Giemsa solution (Merck Millipore, Darmstadt, Germany). Visual inspection of the cell cultures
for the presence of syncytia (multinucleated cells) was used to determine the pH threshold required for
fusion.
Thermostability assay. In short, viruses were diluted to 128 HA units (HAU)/25 l using PBS. The
samples were incubated in a thermal cycler for 30 min at temperatures of 50°C, 51.7°C, 54.3°C, 56°C,
58.5°C, and 60°C. Subsequently, the HA titer was determined by performing a hemagglutination assay
using TRBCs.
Polymerase assay. 293T cell monolayers were transfected with 125 ng of luciferase reporter plasmid
(ﬁreﬂy open reading frame ﬂanked by the noncoding regions of the M segment under control of a PolI
promoter) and 12.5 ng of an internal control plasmid (Renilla gene under the cytomegalovirus [CMV]
promoter) together with the mix of PB2, PB1, PA, and NP plasmids, cloned in a bidirectional reverse
genetics plasmid, in quantities of 125, 125, 125, and 250 ng, respectively. The transfected cells were
incubated at 33°C or 37°C. After 24-h incubation, the supernatants were discarded, and the cell extracts
were prepared in 100 l of lysis buffer. The luciferase levels were assayed with luciferase assay system
(Promega) and detected by a luminometer. Polymerase complexes of control viruses were included in
the assay: a human H1N1 virus A/Hong Kong/54/1998 (HK/98), two human A/H5N1 viruses A/Vietnam/
1203/2004 (VN/1203/04) and A/Indonesia/5/05 (IN/05), and an avian virus A/H5N2 A/mallard/Nether-
lands/3/1999 (ml/NL/99).
Hemagglutination inhibition assay. Ferret antisera were prepared by intranasal inoculation with
500 l recombinant virus containing six gene segments of PR/34 (47), the corresponding HA without the
MBCS, and the corresponding NA. Fourteen days postinoculation, ferrets were boosted by injecting
subcutaneously 500 l of a 1:1 mix of concentrated virus (2,048 HAU) and Titermax Gold adjuvant
(Sigma-Aldrich, St. Louis, MO, USA). Antisera were collected 2 weeks later. Ferret antisera were then
pretreated overnight with receptor-destroying enzyme (VCNA) at 37°C and incubated at 56°C for 1 h the
next day. Antisera were subsequently treated with 10% TRBCs at 4°C for an hour. Twofold serial dilutions
of the antisera, starting at a 1:20 dilution, were mixed with 25 l of a virus stock containing 4
hemagglutinating units and were incubated at 37°C for 30 min. Subsequently, 25 l of 1% TRBCs was
added, and the mixture was incubated at 4°C for 1 h. Hemagglutination inhibition (HI) was read and was
expressed as the reciprocal value of the highest dilution of the serum that completely inhibited
agglutination of virus and erythrocytes. The detection limit corresponds to half of the ﬁrst antisera
dilution (10).
Biosafety. All experiments were conducted within the enhanced animal biosafety level 3 (ABSL3)
facility of Erasmus MC. The ABSL3 facility consists of a negative-pressure laboratory (30 Pa) in which
all in vivo and in vitro experimental work is carried out in class 3 isolators or class 3 biosafety cabinets,
which also have negative pressure (less than200 Pa). Although all experiments are conducted in closed
class 3 cabinets and isolators, special personal protective equipment, including laboratory suits, gloves,
and FFP3 facemasks, is used. Air released from the class 3 units is ﬁltered by high-efﬁciency particulate
air (HEPA) ﬁlters and then leaves via the facility ventilation system, again via HEPA ﬁlters. Only authorized
personnel that have received the appropriate training can access the ABSL3 facility. For animal
handling in the facilities, personnel always work in pairs. The facility is secured by procedures recognized
as appropriate by the institutional biosafety ofﬁcers and facility management at Erasmus MC and Dutch
and U.S. government inspectors.
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